분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-10-15 11:43:46 , Hit : 2982
 Hepatitis C Virus Infection Linked to Fat Enzyme in Liver Cells

ScienceDaily (Oct. 11, 2010) — Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found that an enzyme associated with the storage of fat in the liver is required for the infectious activity of the hepatitis C virus (HCV). This discovery may offer a new strategy for treating the infection.

More than 160 million people are infected throughout the world, and no vaccine is available to prevent further spread of the disease. Current treatments are not effective against the most common strains in the US and Europe. The study, published in the journal Nature Medicine, shows that the enzyme DGAT1 is a key factor in HCV infection. With several potential DGAT1 inhibitors already in the drug-development pipeline, a treatment for HCV may be possible in the near future.

"Our results reveal a potential 'Achilles heel' for HCV infection," said Melanie Ott, MD, PhD, senior author on the study. "Several DGAT1 inhibitors are already in early clinical trials to treat obesity-associated diseases. They might also work against HCV."

At first glance, the HCV lifecycle is fairly simple. The virus enters the cell. One large protein is produced and cut into several smaller viral enzymes and proteins that build the virus. The RNA genome is copied, and the new RNAs and structural proteins are used to make new virus particles that are released into the blood stream for to infect more cells. These processes were thought to occur at specialized membranes inside the cell. However, recently it has been shown that fat droplets are critically involved.

Fat droplets, which store fat in cells, have become a hot new topic in biology. DGAT1 is one of the enzymes that help to form fat droplets. The Gladstone team, led by Eva Herker, PhD, discovered that HCV infection and viral particle production are severely impaired in liver cells that lack DGAT1 activity.

"DGAT enzymes produce the fat that is stored in the droplets that are important for HCV replication, so we wondered if inhibiting those enzymes might disrupt the viral life cycle," said Dr. Herker. "We found that HCV specifically relies on one DGAT enzymes, DGAT1. When we inhibit DGAT1 with a drug, the liver still produces fat droplets through another DGAT enzyme but these droplets cannot be used by HCV."

The team sought to identify which step in the HCV lifecycle requires DGAT1. They found that DGAT1 interacts with one viral protein, the viral nucleocapsid core protein, required for viral particle assembly. The core protein normally associates with the surface of fat droplets but cannot do so when DGAT1 is inhibited or missing in infected cells.

Researchers at Gladstone Institute of Cardiovascular Disease had previously cloned DGAT1.

Charles Harris, Robert V. Farese, Jr. and Katrin Kaehlcke were part of the Gladstone team. Celine Hernadez, Arnaud Charpentier and Arielle Rosenberg supported the research from the Universite Paris Descartes.

This work was supported by funds from the Gladstone Institutes, the Hellman Family Foundation, the US National Institutes of Health and the UCSF Liver Center. Additional support was provided through fellowships from the Human Frontiers Science Program, the Agence nationale de recherches sur le sida et les hépatites virales, and a training grant from the National Institute of Diabetes and Digestive and Kidney Diseases.

Journal Reference:

Eva Herker, Charles Harris, Céline Hernandez, Arnaud Carpentier, Katrin Kaehlcke, Arielle R Rosenberg, Robert V Farese, Melanie Ott. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nature Medicine, 2010; DOI: 10.1038/nm.2238







787   Gene Editing Treats Blood Disease  이성욱 2011/07/16 3067
786   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes  이성욱 2013/04/23 3060
785   The Sugar Lnc  이성욱 2012/05/10 3037
784   A targeted cancer therapy? - small conditional RNA  이성욱 2010/09/08 3023
783   More support for transcription trickPosted by Jef Akst  이성욱 2010/05/01 3006
782   Roche hepatitis C drug appears safe in combination  이성욱 2010/10/17 3003
781   면역 시스템을 가지는 바이러스  이성욱 2013/03/01 2994
780   배아 발달 동안 돌연변이와 성인에서 암 발병 관련성  이성욱 2012/06/18 2987
779   유전자 특허 불인정 판결의 후폭풍: 멘붕에 빠진 미 BT 업계  이성욱 2013/06/20 2985
  Hepatitis C Virus Infection Linked to Fat Enzyme in Liver Cells  이성욱 2010/10/15 2982
777   Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2967
776   Gene Therapy Appears to Help Patient With Anemia  이성욱 2010/09/17 2966
775   Viruses in the gut protect from infection  이성욱 2013/05/22 2948
774   Molecular scalpel hope for Duchenne muscular dystrophyBy James Gallagher  이성욱 2011/07/28 2945
773   Pluripotency not required !!!  이성욱 2010/01/28 2940
772   Autistic Mice Act a Lot Like Human Patients: Geneticists Develop Promising Mouse Model for Testing New Autism Therapies  이성욱 2011/10/06 2936
771   Why brain tumors hard to treat  이성욱 2010/11/23 2926
770   C형간염 진단 유전자검사 개발  이성욱 2013/03/07 2925
769   줄기세포 이식으로 HIV 감염 완치: 세계 3번째, 4번째의 HIV 완치 환자 등장  이성욱 2013/07/05 2914
768   More support for RNAi in clinic  이성욱 2010/03/23 2910

[이전 10개] [1]..[21][22][23][24] 25 [26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN